These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3484649)
1. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy. Collins AJ; Davies J; Dixon SA Br J Rheumatol; 1986 Feb; 25(1):50-3. PubMed ID: 3484649 [TBL] [Abstract][Full Text] [Related]
2. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Collins AJ; Du Toit JA Br J Rheumatol; 1987 Aug; 26(4):295-8. PubMed ID: 3496934 [TBL] [Abstract][Full Text] [Related]
3. [Endoscopic study of digestive lesions caused by the use of nonsteroidal anti-inflammatory agents in rheumatic patients]. van Linthoudt D; Kocher F; Ott H Schweiz Med Wochenschr; 1987 Apr; 117(16):604-8. PubMed ID: 3495881 [TBL] [Abstract][Full Text] [Related]
4. UPPER GASTROINTESTINAL ENDOSCOPY FINDINGS IN PATIENTS REFERRED WITH UPPER GASTROINTESTINAL SYMPTOMS IN ELDORET, KENYA: A RETROSPECTIVE REVIEW. Ayuo PO; Some FF; Kiplagat J East Afr Med J; 2014 Aug; 91(8):267-73. PubMed ID: 26862651 [TBL] [Abstract][Full Text] [Related]
5. Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions. Upadhyay R; Torley HI; McKinlay AW; Sturrock RD; Russell RI Ann Rheum Dis; 1990 Jun; 49(6):359-62. PubMed ID: 2383058 [TBL] [Abstract][Full Text] [Related]
6. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Janssen M; Dijkmans BA; van der Sluys FA; van der Wielen JG; Havenga K; Vandenbroucke JP; Lamers CB; Zwinderman AH; Cats A Br J Rheumatol; 1992 Nov; 31(11):747-52. PubMed ID: 1450796 [TBL] [Abstract][Full Text] [Related]
7. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia]. Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R Digestion; 2003; 68(4):198-208. PubMed ID: 14707396 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls. Sheikh RA; Romano PS; Prindiville TP; Yasmeen S; Trudeau W J Clin Gastroenterol; 2002; 34(5):529-32. PubMed ID: 11960063 [TBL] [Abstract][Full Text] [Related]
10. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Silvoso GR; Ivey KJ; Butt JH; Lockard OO; Holt SD; Sisk C; Baskin WN; Mackercher PA; Hewett J Ann Intern Med; 1979 Oct; 91(4):517-20. PubMed ID: 314764 [TBL] [Abstract][Full Text] [Related]
11. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists. Mitchell RM; Collins JS; Watson RG; Tham TC Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401 [TBL] [Abstract][Full Text] [Related]
12. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases]. Karateev AE; Nasonova VA; Murav'ev IuV Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549 [TBL] [Abstract][Full Text] [Related]